DARPA SPONSORS PAINLESS BLOOD-TESTING DEVICE FROM TASSO INC.
Tasso Inc. has received a DARPA grant to develop their device, the HemoLink, to provide patients with a pain-free alternative to blood draws. Performing a blood draw requires a trained professional and can be stressful and painful for patients.
The device relies on microfluidic technology and a special vacuum chamber designed to collect blood over a two minute period. HemoLink slowly pulls blood out of capillaries through a microchannel without a needle. The beauty of HemoLink is that it is self-administered and easy to use. Upon completion of the draw, the patient simply takes the sample to a lab for testing.
DARPA has also given Tasso Inc. $3 million to develop a preservative to extend the shelf-life of the blood samples to a week, and the storage temperature up to 60°C (140° F)
HemoLink can potentially lessen workloads in hospitals and clinics because it is an easy way for patients to get blood testing done on their own time, pain-free and without a needle.
WRITE A COMMENT
REHABILITATION DEVICE (MUSICGLOVE) RESTORES USE OF HAND AFTER STROKE
LIQUID BIOPSY: A NEW METHOD FOR IDENTIFYING CANCER
ECHOPIXEL DEVELOPS TRUE 3D VIEWER THAT CONVERTS STANDARD 2D IMAGES TO ...
FIRST CLINICAL TRIALS OF NEW HANDHELD AUTOFLUORESCENCE IMAGING PLATFOR ...
BIMEDIS TEAM AT THE EUROPEAN CONGRESS OF RADIOLOGY 2015
A CORNUCOPIA OF FOOD SIGNS IN RADIOLOGY